MediWound (MDWD) Net Cash Flow (2013 - 2026)
MediWound (MDWD) posted Net Cash Flow of -$11.1 million for Q2 2026, down 205.06% on a QoQ basis from $10.6 million in Q1 2026, and down 3580.79% year-over-year from $319352.4 in Q2 2025.
Analysis
MediWound (MDWD) Net Cash Flow (2013 - 2026) Analysis & Trends
MediWound has reported Net Cash Flow for 14 years, with the latest figure at -$11.1 million in Q2 2026.
- On a quarterly basis, Net Cash Flow fell 3580.79% year-over-year to -$11.1 million in Q2 2026; TTM through Jun 2026 was $3.1 million, a 212.95% increase from a year earlier, with the FY2025 full-year figure at -$4.5 million, down 69.43% from the prior year.
- Net Cash Flow was -$11.1 million for Q2 2026 at MediWound, down from $10.6 million in the prior quarter.
- The five-year high for Net Cash Flow was $31.7 million in Q3 2025, with the low at -$31.7 million in Q2 2023.
- Average Net Cash Flow over 5 years is -$153777.8, with a median of $953500.0 recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: Net Cash Flow surged 1087.29% in 2025, then slumped 3580.79% in 2026.
- Over 5 years, Net Cash Flow stood at $17.8 million in 2022, then slumped by 87.58% to $2.2 million in 2023, then gained by 21.23% to $2.7 million in 2024, then plunged by 1145.52% to -$28.0 million in 2025, then soared by 60.3% to -$11.1 million in 2026.
- The last three Net Cash Flow figures came in at -$11.1 million (Q2 2026), $10.6 million (Q1 2026), and -$28.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -4.43 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 652.90 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -504.30 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -183.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -496,000.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -170.75 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | -11.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.12 Mn |
| Mar 31, 2026 | 10.58 Mn |
| Dec 31, 2025 | -28.00 Mn |
| Sep 30, 2025 | 31.67 Mn |
| Jun 30, 2025 | -302,000.00 |
| Mar 31, 2025 | -7.82 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | -881,000.00 |
| Mar 31, 2024 | -7.09 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Sep 30, 2023 | -9.81 Mn |
| Jun 30, 2023 | -31.73 Mn |
| Mar 31, 2023 | 17.46 Mn |
| Dec 31, 2022 | 17.78 Mn |
| Sep 30, 2022 | 11.70 Mn |
| Jun 30, 2022 | -8.62 Mn |
| Mar 31, 2022 | 5.85 Mn |
| Dec 31, 2021 | -2.53 Mn |
| Sep 30, 2021 | -3.30 Mn |